A novel aminosterol reverses diabetes and fatty liver disease in obese mice
- 30 September 2004
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 41 (3), 391-398
- https://doi.org/10.1016/j.jhep.2004.05.006
Abstract
No abstract availableFunding Information
- National Institutes of Health (RO1-DK62348)
This publication has 21 references indexed in Scilit:
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Divergent Effects of Leptin in Mice Susceptible or Resistant to ObesityHormone and Metabolic Research, 2002
- Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight LossScience, 2002
- Diet-induced insulin resistance in mice lacking adiponectin/ACRP30Nature Medicine, 2002
- Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance in Lep/Lep MiceOnline Journal of Public Health Informatics, 2002
- Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2002
- Animal Models of SteatosisSeminars in Liver Disease, 2001
- Transcriptional Profiling Reveals Global Defects in Energy Metabolism, Lipoprotein, and Bile Acid Synthesis and Transport with Reversal by Leptin Treatment in Ob/ob Mouse LiverOnline Journal of Public Health Informatics, 2001
- A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic propertiesInternational Journal of Obesity, 2001
- Precision and Accuracy of Dual‐Energy X‐ray Absorptiometry for Determining in Vivo Body Composition of MiceObesity Research, 2000